Latest News and Press Releases
Want to stay updated on the latest news?
-
ICP-488 is expected to provide a novel therapeutic option for patients. There are no approved targeted therapies for Sjögren's syndrome globally.
Want to stay updated on the latest news?
ICP-488 is expected to provide a novel therapeutic option for patients. There are no approved targeted therapies for Sjögren's syndrome globally.